Table 3.
Patient No. in Dataset | Patient Not in 10-Yr Paper | Duration of Clozapine Treatment, Months | ICD-9 Diagnosis | Gender | Cardiovascular Event | Race | Age at Time of Event, Year | Clozapine Dose (mg/d) | BMI (kg/m2) | Diabetes after Clozapine Initiation | Smoking Status |
---|---|---|---|---|---|---|---|---|---|---|---|
5 | 1 | 36 | 295.3 | Male | Non-fatal MI | White | 50 | 525 | 26.48 | No | Yes |
5 | 146 | 295.3 | Male | Fatal MI | White | 57 | |||||
8 | 132 | 295.7 | Male | Non-fatal CVA | White | 37 | 500 | 36 | Yes | ||
9 | 11 | 84 | 295.9 | Male | Non-fatal CVA | White | 45 | 400 | 17 | Yes | Yes |
18 | 54 | 295.3 | Female | Fatal CVD | White | 59 | |||||
19 | 2 | 108 | 295.9 | Male | Non-fatal MI | White | 49 | 450 | 35 | Yes | Yes |
23 | 108 | 295.3 | Female | Non-fatal LVH | White | 50 | 500 | No | Yes | ||
23 | 6 | 120 | 295.3 | Female | Fatal MI | White | 51 | 500 | 51 | No | Yes |
26 | 84 | 295.3 | Male | Fatal MI | White | 50 | 550 | 26 | No | Yes | |
30 | 156 | 295.7 | Male | Non-fatal MI | White | 63 | 500 | 26 | No | Yes | |
35 | 6 | 295.3 | Male | Non-fatal LVH | White | 27 | 400 | 27 | No | No | |
37 | 36 | 295.3 | Female | Fatal CVD | White | 45 | 125 | 31 | Yes | Yes | |
70 | 160 | 295.7 | Female | Non-fatal LVH | White | 38 | 550 | 35 | Yes | No | |
75 | 8 | 108 | 295.7 | Male | Fatal CVD | Hispanic | 29 | 43 | Yes | Yes | |
79 | 4 | 24 | 295.3 | Female | Fatal CVD | African American | 26 | 175 | 39 | Yes | No |
94 | 120 | 295.3 | Male | Fatal MI | White | 49 | 27 | No | Yes | ||
98 | 3 | 84 | 295.1 | Female | Non-fatal MI | White | 42 | 350 | 29 | No | Yes |
ICD: International classification of diseases; 295.1: disorganized type schizophrenia; 295.3: paranoid type schizophrenia; 295.7: schizoaffective disorder; 295.9: unspecified schizophrenia; BMI: Body Mass Index; CVA: cerebrovascular accident; CVD: MI cardiovascular disease; MI: myocardial infarction; LVH: left ventricular hypertrophy; MVI: multivitamin.